Skip to main content
    F

    Fennec Pharmaceuticals Inc (FENC)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $12.76
    +1.14 (+9.81%)

    Market Cap: $410.25M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Fennec Pharmaceuticals Inc (FENC) P/E Ratio & Valuation Multiples

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Fennec Pharmaceuticals (FENC) trades at 159.5x trailing earnings and 6.8x sales. Its P/S of 6.8x is above its 5-year median of 5.9x. Its forward P/E is 13.6x.

    Current Multiples

    Its forward P/E is below its trailing P/E, which implies earnings per share about 1072.8% higher over the next year.

    MultipleValue
    P/E (trailing)159.5x
    Forward P/E13.6x
    Price to sales6.8x
    Price to book9.1x
    EV/EBITDA102.2x
    PEG1.5
    As of Nov 17, 2026

    Historical Medians

    MultipleCurrent5-year median10-year median
    P/S6.8x5.9xN/A
    Medians of month-end values through Oct 2026: 48 months (5-year).

    Valuation History

    Over the 4 of the 10 year ends shown that have a P/S, its P/S ranged from 3.6x in 2024 to 164.9x in 2022.

    Year endPriceP/SP/B
    2025$7.705.0x6.8x
    2024$6.323.6xN/A
    2023$11.2214.1xN/A
    2022$9.60164.9xN/A
    2021$4.40N/A7.3x
    2020$7.45N/A6.1x
    2019$6.49N/A11.0x
    2018$6.38N/A6.0x
    2017$10.02N/A5.7x
    2016$2.14N/A7.6x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported.

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About FENC

    What is FENC's forward P/E ratio?

    Fennec Pharmaceuticals has a forward P/E ratio of 13.6x.

    Is FENC stock overvalued?

    GNG's valuation label for FENC is Undervalued.

    What is FENC's price to sales ratio?

    Fennec Pharmaceuticals has a price to sales ratio of 6.8x.

    What is FENC's PEG ratio?

    Fennec Pharmaceuticals has a PEG ratio of 1.5.